証拠の質 4.63/5
8次元のレビュー評価。基準は 品質ルーブリック 。各次元は1〜5で評価。
- D1 出典への根拠
- 4/5
- D2 出典の権威性
- 5/5
- D3 算術
- 5/5
- D4 不確実性
- 4/5
- D5 範囲
- 5/5
- D6 文章
- 5/5
- D7 認識の誠実性
- 4/5
- D8 注意事項の完全性
- 5/5
リスクはどう変わるか
見出しの数値は大きく異なる状況の平均です。シナリオや文脈による確率の違いは以下の通りです:
1,000,000分の1
Structural floor. Ambient RF power density from cell towers at ground level is typically 1,000-10,000x below ICNIRP general public limits. No epidemiological study has found elevated cancer incidence in populations living near base stations. Multiple ecological studies (UK, Germany, Israel) have looked; none found a signal after controlling for confounders.
200,000分の1
Placeholder reflecting the INTERPHONE top-decile finding (OR 1.40 for glioma) which the study authors attributed to bias. If the association were causal, the absolute risk increase over a baseline lifetime glioma rate of ~0.6% would be small. The FDA and WHO do not consider this finding sufficient to establish causation.
333,333分の1
Telecom workers installing and maintaining antennas can experience near-field exposures closer to ICNIRP occupational limits. Occupational studies have not found consistent cancer elevation, but sample sizes are small. ICNIRP occupational limits are set with a 50x reduction factor below thermal thresholds.
1,000,000分の1
mmWave radiation is absorbed in the outer layers of skin and does not penetrate to internal organs. ICNIRP 2020 guidelines explicitly cover these frequencies. No epidemiological data exists for mmWave-specific cancer risk because population-scale exposure only began in 2020. The physics of shallow penetration depth makes internal organ effects implausible at guideline-compliant levels.
バーの長さと濃淡は、これらのシナリオを他のリスクとではなく、互いに比較して順位付けしたものです。正確な確率は各項目の横に表示されています。
RF-EMFとがんに関するエビデンスは、規制機関の間で異例なほど意見が分かれています。 IARCは2011年に、無線周波数電磁界をグループ2B(「発がん性がある可能性がある」)に分類しました。これは主に、INTERPHONE研究で、累積電話使用量が最も多い上位10%のグループにおいて、神経膠腫のリスクが40%上昇したという知見に基づいています。しかし、この結果については、研究著者自身が、想起バイアスと選択バイアスのために因果関係を解釈できないと述べています。INTERPHONE研究における神経膠腫の全体的なオッズ比は、実際には1.0を下回っており(OR 0.81)、誰もが人工的なものと認める保護効果を示唆していました。一方、FDAの2020年のレビュー、WHO EMF Project、ICNIRPの2020年のガイドライン更新、およびUK COMAREの第18次報告書はすべて、ガイドラインに準拠したレベルでのRF-EMF曝露とがんとの間に因果関係があるという証拠は支持されないと結論付けています。ICNIRPの2020年のガイドラインは、300 GHzまでの5G周波数を明示的に対象としており、1998年の曝露制限を改訂する科学的根拠は見当たらず、明確化のためにその形式を再構築しただけです。
5Gに対する懸念を特徴づけているのは、科学よりも社会学的な側面です。5Gの展開はCOVID-19パンデミックと時期が重なり、両者を結びつける陰謀論が、2020年初頭に英国、アイルランド、オランダ全土で数十の携帯電話基地局に対する放火攻撃を引き起こしました。IARCの2B分類(リスク定量化ではなく、ハザード特定ラベルとして設計されたもの)は、文脈を無視され、「WHOが携帯電話はがんを引き起こすと言っている」という証拠として日常的に提示されました。グループ2Bには、アロエベラ全葉抽出物、漬物、タルクパウダーなど、300以上の物質が含まれています。これは、無視できない限られた証拠が存在するという意味であり、リスクが確立されたという意味ではありません。IARCの枠組み(「あらゆる曝露シナリオでこれががんを引き起こす可能性はあるか?」と問うもの)とWHOのリスク評価(「実世界のレベルでこれががんを引き起こすか?」と問うもの)の区別は微妙であり、メディア報道では体系的に見過ごされています。
携帯電話をポケットに入れるという副次的な疑問については、このサイトの精巣熱曝露に関する項目で、より強力な証拠経路が扱われています。それは、RF特有の発がん性ではなく、デバイスの熱による精液パラメータへの熱効果です。Adamsの2014年のメタアナリシスでは、携帯電話曝露に関連して8.1%の運動性低下が認められましたが、信頼区間は広く、含まれる研究はin vitro照射と観察的自己申告が混在しており、生殖能力の結果を測定した研究はありませんでした。American Cancer Societyは、精巣がんのリスク要因としてRF-EMFを挙げていません。5Gに特化すると、ミリ波周波数(24-39 GHz)は皮膚の表層で吸収され、内臓には浸透しません。これは物理的な制約であり、ICNIRP準拠の電力レベルでは内部がんのリスクはありそうにないことを意味します。ただし、これらの周波数における集団規模の疫学データは、展開がごく最近であるため、まだ存在していません。
関連する豆知識
5G基地局は安全基準の数千倍以下の出力で非電離放射線を放出する。健康被害の生物学的メカニズムは存在しない。WHO、FDA、ICNIRPが一致している。不安は本物。リスクは本物ではない。
根拠台帳
以下の各数値は各出典が報告した内容であり、引用した原文の抜粋と算出方法を記載しています。リンクをクリックして直接確認できます。
1/6 件の出典が引用元と一字一句一致することを独立して検証済み
-
[1] International Agency for Research on Cancer (WHO/IARC) — IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans
IARC classifies radiofrequency electromagnetic fields as possibly carcinogenic to humans- 統計値
RF-EMF classified as Group 2B ('possibly carcinogenic to humans') based on limited evidence of glioma in heavy mobile phone users- 抜粋
“"The evidence was reviewed critically, and overall evaluated as being limited among users of wireless telephones for glioma and acoustic neuroma, and inadequate to draw conclusions for other types of cancers. The evidence from the occupational and environmental exposures mentioned above was similarly judged inadequate. The Working Group did not quantitate the risk; however, one study of past cell phone use (up to the year 2004), showed a 40% increased risk for gliomas in the highest category of heavy users (reported average: 30 minutes per day over a 10-year period)." ”
- 出典データ
- 2011-05-31
- アクセス日
- 2026-04-18 · アーカイブ版
- 計算過程
- The IARC Monograph 102 Working Group evaluated RF-EMF based primarily on the Interphone study (2010) and Hardell group case-control studies. The 40% glioma increase was observed only in the highest decile of cumulative call time in Interphone, and the Interphone authors themselves cautioned that recall bias and selection bias could account for the finding. Group 2B is IARC's second-lowest risk category — it indicates limited evidence in humans and less than sufficient evidence in animals. Over 300 agents are classified 2B, including aloe vera extract, pickled vegetables, and occupational dry cleaning. The classification does not constitute a risk quantification.
-
[2] International Commission on Non-Ionizing Radiation Protection (ICNIRP) — Guidelines for Limiting Exposure to Electromagnetic Fields (100 kHz to 300 GHz)
Guidelines for Limiting Exposure to Electromagnetic Fields (100 kHz to 300 GHz)- 統計値
ICNIRP 2020 guidelines set exposure limits with large safety factors; 5G frequencies (sub-6 GHz and mmWave up to 300 GHz) remain non-ionizing and within the same framework- 抜粋
“"There are no adverse health effects of RF EMF exposure in the frequency range and at the exposure levels relevant for the guidelines described here, other than those related to body temperature rise. A thorough review of the scientific literature published since the 1998 guidelines has not revealed a need to revise the basic restrictions on scientific grounds, although the form of the guidelines has been changed considerably." ”
- 出典データ
- 2020-03-11
- アクセス日
- 2026-04-18 · アーカイブ版
- 計算過程
- ICNIRP's 2020 update reviewed the entire post-1998 literature, including studies at frequencies used by 5G (sub-6 GHz and mmWave 24-300 GHz). The guidelines explicitly cover 5G frequencies. The only confirmed health effect at these frequencies is tissue heating, and the exposure limits incorporate reduction factors of 50x (occupational) to 200x (general public) below thresholds where thermal effects begin. Actual 5G small cell power output is typically lower per base station than 4G macro towers because of the densified architecture. ICNIRP is the independent scientific body whose guidelines are adopted by most national regulators outside the US (the FCC uses IEEE standards that reach similar conclusions).
-
[3] The Lancet Oncology / INTERPHONE Study Group — Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study
Brain tumour risk in relation to mobile telephone use: results of the INTERPHONE international case-control study- 統計値
No overall increased risk of glioma or meningioma with mobile phone use; OR 0.81 (95% CI 0.70-0.94) for glioma overall; elevated OR 1.40 (95% CI 1.03-1.89) only in the highest decile of cumulative call time- 抜粋
“"Overall, no increase in risk of glioma or meningioma was observed with use of mobile phones. There were suggestions of an increased risk of glioma at the highest exposure levels, but biases and error prevent a causal interpretation." ”
- 出典データ
- 2010-05-17
- アクセス日
- 2026-04-18
- 計算過程
- The INTERPHONE study is the largest case-control study of cell phone use and brain tumors, covering 13 countries with 2,708 glioma cases and 2,409 meningioma cases. The overall odds ratio for glioma was protective (0.81), which the authors attributed to participation bias. The elevated OR in the top decile (1.40) is the primary finding that drove the IARC 2B classification. The authors explicitly stated that "biases and error prevent a causal interpretation" of the top-decile result. The study covered phone use up to 2004 — before 4G, let alone 5G — and measured cumulative call time, not ambient tower exposure.
- 独立性
- INTERPHONE is the primary study underlying the IARC classification; the IARC source above is a downstream interpretation of this and other data. They are not independent but serve different roles — INTERPHONE provides the data, IARC provides the regulatory classification.
-
[4] US Food and Drug Administration — Scientific Evidence for Cell Phone Safety (Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer)
Scientific Evidence for Cell Phone Safety (Review of Published Literature between 2008 and 2018 of Relevance to Radiofrequency Radiation and Cancer)- 統計値
FDA concluded that the weight of scientific evidence does not support the conclusion that non-ionizing RF energy from cell phones causes cancer- 抜粋
“"Based on the evaluation of the currently available information, the FDA believes that the weight of the scientific evidence does not support an increase in health risks from radio frequency exposure from cell phone use at or below the radio frequency exposure limits set by the FCC." ”
- 出典データ
- 2020-02-10
- アクセス日
- 2026-06-30 · アーカイブ版
- 計算過程
- The FDA's 2020 review covered epidemiological, animal, and in vitro studies published between 2008 and 2018. The review explicitly addressed the NTP (National Toxicology Program) rat study, which found some evidence of schwannoma in male rats exposed to whole-body RF at SAR levels 2-8x the human safety limit for 9 hours/day over 2 years. The FDA concluded that the NTP results were not generalizable to human cell phone use because of the vastly higher exposure levels and whole-body irradiation protocol. This is the US regulatory counterpart to ICNIRP; both bodies reached the same conclusion using different review processes.
- 独立性
- The FDA review is an independent US regulatory assessment. It evaluates some of the same underlying studies as IARC Monograph 102 but applies a different weight-of-evidence framework and reaches a distinct conclusion about the sufficiency of evidence for a causal link.
-
[5] World Health Organization — Electromagnetic fields and public health: mobile phones
Electromagnetic fields and public health: mobile phones- 統計値
WHO states that there is no evidence to conclude that exposure to low level electromagnetic fields is harmful to human health- 抜粋
“"Despite extensive research, to date there is no evidence to conclude that exposure to low level electromagnetic fields is harmful to human health. … The user of a mobile phone encounters field levels that are much higher than any levels in the normal living environment. However, even these increased levels do not appear to generate harmful effects." ”
- 出典データ
- 2014-10-08
- アクセス日
- 2026-04-18 · アーカイブ版
- 計算過程
- The WHO EMF Q&A page is the most widely cited public-health summary on mobile phone safety. It post-dates the IARC 2B classification and explicitly notes that the overall evidence does not suggest detrimental effects. WHO's own position — "no evidence to conclude that exposure to low level electromagnetic fields is harmful" — is more conservative than the Group 2B label, reflecting the difference between IARC's hazard identification framework (which asks "could this ever cause cancer under any conditions?") and WHO's risk assessment framework (which asks "does this cause cancer at real-world exposure levels?").
-
[6] Environment International (Adams, Galloway, Mondal, Esteves & Mathews, 2014) — Effect of mobile telephones on sperm quality: a systematic review and meta-analysis 検証済み
Effect of mobile telephones on sperm quality: a systematic review and meta-analysis- 統計値
Meta-analysis of 10 studies (1,492 samples) found mobile phone exposure associated with an 8.1% reduction in sperm motility (mean difference -8.1%, 95% CI -13.1 to -3.2)- 抜粋
“"Exposure to mobile phones was associated with reduced sperm motility (mean difference -8.1% (95% CI -13.1, -3.2))." ”
- 出典データ
- 2014-09-01
- アクセス日
- 2026-07-03 · アーカイブ版
- 検証
- グラウンディング監査の際、抜粋を引用元から独立して再取得し、原文と一字一句一致することを確認しました。
- 計算過程
- Adams et al. (2014, Environment International) pooled 10 studies covering 1,492 semen samples, mixing in vitro irradiation experiments with observational self-report studies. This is the source for the "8.1% motility reduction" figure cited in the body's phone-in-pocket aside; the wide confidence interval (-13.1 to -3.2) is why the body describes the finding as uncertain. No study in the meta-analysis measured actual fertility or conception outcomes, only semen parameters. This source is unrelated to this entry's own cancer-risk conclusion — it backs only the tangential thermal/sperm-quality mention, which is covered in full on the separate testicular-heat-exposure entry.